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Actobindin is a protein from Acanthamoeba castel- 
lanii with bivalent affinity for monomeric actin. Be- 
cause it can bind two molecules of actin, actobindin is 
a substantially more potent inhibitor of the early phase 
of actin polymerization than of F-actin elongation. The 
complete amino acid sequence of 88 residues has been 
deduced from the determined sequences of overlapping 
peptides obtained by cleavage with trypsin, Staphylo- 
coccus VS protease, endoproteinase Asp-N, and CNBr. 
Actobindin contains 2 trimethyllysine residues and an 
acetylated NH2 terminus. About 76% of the actobindin 
molecule consists of two nearly identical repeated seg- 
ments of -33 residues each. This could explain acto- 
bindin’s bivalent affinity for actin. The circular di- 
chroism spectrum of actobindin is consistent with 15% 
a-helix and 22% p-sheet structure. A hexapeptide with 
sequence LKHAET, which occurs at the beginning of 
each of the repeated segments of actobindin, is very 
similar to sequences found in tropomyosin, muscle my- 
osin heavy chain, paramyosin, and Dictyostelium a- 
actinin. A longer stretch in each repeated segment is 
similar to sequences in mammalian and amoeba profi- 
lins. Interestingly, the sequences around the trime- 
thyllysine residues in each of the repeats are similar to 
the sequences flanking the trimethyllysine residue of 
rabbit reticulocyte elongation factor la, but not to the 
sequences around the trimethyllysine residues in Acan- 
thamoeba actin and Acanthamoeba profilins I and II. 
Eukaryotic cells contain many actin-binding proteins that 
regulate the polymerization of actin and the supramolecular 
organization of the microfilament system (for reviews, see 
Refs. l-4). These proteins are generally classified as either 
G-actin- or F-actin-binding proteins. Among the best studied 
examples of G-actin-binding proteins are the profilins; they 
have been isolated from a large variety of cells including 
vertebrates (5,6), invertebrates (7), and protozoa (8-10). The 
profilins form 1:l complexes with monomeric actin in a simple 
equilibrium reaction (11,12), thus “buffering” (11) the polym- 
erization process by providing a regulatable (13, 14) pool of 
polymerization-competent monomers. When studied in vitro, 
the initial rate of actin polymerization, the rate of elongation 
of F-actin, and the concentration of F-actin formed at steady 
state are all diminished, as expected, in proportion to the 
amount of monomeric actin that is sequestered in the profilin- 
actin complex. 
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Recently, Lambooy and Korn (15, 16) purified another G- 
actin-binding protein, actobindin, from the cytoplasm of 
Acanthamoeba castellanii. Initially, based on the extent to 
which actobindin inhibited the rate of elongation of F-actin 
and its concentration at steady state, they concluded (15) that 
actobindin (which was then believed to be a homodimer of a 
12,500-Da polypeptide) bound a single actin monomer in 
much the same manner as the profilins. Then, Lambooy and 
Korn (16) discovered that, in contrast to the profilins, acto- 
bindin is a much more potent inhibitor of the initial phase of 
actin polymerization than could be explained by its formation 
of a 1:l complex with actin monomer. These latter observa- 
tions gave rise to the hypothesis (16) that, again in contrast 
to the profilins, actobindin may interact with an early inter- 
mediate in the actin polymerization process (e.g. a dimer or 
trimer) in addition to its interaction with monomeric G-actin. 
Recent sedimentation equilibrium studies (17) have estab- 
lished that actobindin is, in fact, a monomer of M, -9000 that 
binds two actin monomers at high concentrations of G-actin 
and one actin monomer at low concentrations of G-actin. 
These data provide the basis for a reasonable explanation of 
the complex effects of actobindin on the kinetics of actin 
polymerization (17). 
To understand the details of the interactions of actobindin 
and actin at the structural level, we have determined its amino 
acid sequence by conventional amino acid sequencing meth- 
ods. We report now that actobindin comprises a total of 88 
amino acids in an unusually symmetrical structure with two 
nearly identical segments arranged in tandem. This internal 
repeat could account for actobindin’s bivalent affinity for 
monomeric actin. Short segments within these internal repeat 




Actobindin, isolated according to a previously described 
procedure (15), was further purified by chromatography on a 
Cq reverse-phase column. Unsuccessful attempts to obtain an 
NHz-terminal sequence of the intact protein by Edman deg- 
radation provided convincing evidence that the NH, terminus 
was blocked. 
Actobindin was then cleaved with CNBr at its single me- 
thionine residue (Table I). Reverse-phase HPLC’ of the CNBr 
cleavage products yielded a single component (CNBr-actobin- 
’ Portions of this paper (including “Experimental Procedures,” 
Figs. 1 and 3, and Tables I and II) are presented in miniprint at the 
end of this paper. Miniprint is easily read with the aid of a standard 
magnifying glass. Full size photocopies are included in the microfilm 
edition of the Journal that is available from Waverly Press. 
’ The abbreviations used are: HPLC, high-performance liquid chro- 
matography; PTH, phenylthiohydantoin. 
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din), which eluted with the same retention time as intact 
actobindin (Fig. 1, A and B). CNBr-actobindin was also 
indistinguishable from intact actobindin by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis. In addition, except 
for the absence of the single methionine residue, the amino 
acid composition of CNBr-actobindin was essentially identi- 
cal to that of the uncleaved protein (Table I). The NH2 
terminus of CNBr-actobindin was not blocked, and it was 
successfully sequenced through 30 cycles (Table II). These 
data established that the single methionine residue of acto- 
bindin is at or close to its NH, terminus (see below). 
To determine the complete amino acid sequence, aliquots 
(-200 rg each) of intact actobindin were digested with several 
different proteases, and the respective peptide mixtures were 
separated by reverse-phase HPLC (Fig. 1, C-E). Each of the 
purified peptides was then subjected to gas-phase sequence 
analysis (Table II). All of the peptide sequences could be 
aligned in a single unique sequence (Fig. 2, upper). 
The sequence of the amino acids at the blocked NH2 ter- 
minus of actobindin was deduced by comparing the amino 
acid composition of an acid hydrolysate of the NHz-terminal 
V8 protease peptide (residues l-4) with the NH&erminal 
sequence of CNBr-actobindin. Methionine was the only resi- 
due detected in the V8 protease peptide that was not observed 
in the NH&erminal sequence of CNBr-actobindin. This iden- 
tified methionine as the blocked NHz-terminal residue. 
The sequence at the COOH terminus of actobindin was 
confirmed by amino acid analysis of the COOH-terminal V8 
protease peptide (residues 84-88). Lysine, alanine, and glu- 
tamic acid (derived from the COOH-terminal glutamine) were 
present at a molar ratio of 1.8:2.0:1.0, which is consistent with 
the COOH-terminal sequence of -Lys-Ala-Ala-Lys-Gln. 
At the steps in the sequencing cycles of peptides Asp-N(22) 
and Asp-N(67) (Table II) that corresponded to positions 35 
and 72 of the native protein, respectively, modified phenyl- 
thiohydantoin-derivatives were obtained whose elution posi- 
tions in the conventional on-line phenylthiohydantoin-deriv- 
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FIG. 2. Amino acid sequence of actobindin deduced from 
overlapping peptides and fragments. Upper, the complete se- 
quence in one-letter notation. AC, acetyl group; E, W-trimethyllysine. 
Peptides which were sequenced are indicated by solid lines below the 
sequence. NH2-terminal blocked peptides which could not be se- 
quenced are indicated by broken lines. Only the peptides necessary to 
provide unambiguous overlaps are identified; the sequences of other 
peptides were consistent with these data. Row a, sequence of CNBr- 
actobindin; row b, sequences of tryptic peptides; ro‘ow c, sequences of 
Asp-N peptides; row d, sequences of StaphyEoeoccus aureus V8 pro- 
tease peptides; ro’ow e, sequences of V8 protease peptides derived from 
the blocked NH*-terminal tryptic peptide. The HPLC chromatograms 
of the purifications of the peptides in rows o-e are shown in Fig. 1, 
B-F, respectively. Lower, the sequence of residues 15-84 is aligned to 
illustrate the nearly identical internal repeat. Identical amino acids 
are connected by solid lines and conservative substitutions by dotted 
lines. 
ative analysis system were close to that of phenylthiohydan- 
toin-arginine. As actobindin contains 2 trimethyllysine 
residues (15) and none of the other residues in any of the 
peptides that were sequenced was found to be modified, we 
assigned the trimethyllysines to positions 35 and 72. 
Three lines of evidence indicate that the deduced sequence 
of actobindin (Fig. 2, upper) accounts for the complete poly- 
peptide. (i) The amino acid composition calculated from the 
sequence data is almost identical to that obtained by direct 
analysis of actobindin and CNBr-actobindin (minus methio- 
nine) (Table I); (ii) the sequences of all of the peptides 
produced by proteolysis, including those not shown, are ac- 
commodated by the sequence; and (iii) the M, of 9682 calcu- 
lated from the sequence agrees well with the value from 
sedimentation equilibrium (-9000). In addition, plasma de- 
sorption mass spectrometry of native actobindin and proteo- 
lytic fragments derived from it established the presence of an 
NH&erminal acetyl grou~.~ 
The most striking feature of the actobindin sequence is 
that 76% of the polypeptide is contained within two tandemly 
repeated, nearly identical segments of 33 and 34 amino acids 
(Fig. 2, lower); 24 of the amino acids in residues 15-47 and 
residues 51-83 are identical, and 5 others are conservative 
substitutions. Secondary structure algorithms (19,20) predict 
an a-helix configuration for residues 3-14 and an a-helix-@- 
sheet-a-helix configuration for the two repeats (residues 33- 
38 and 70-75 in P-sheet and the rest of the repeat sequences 
in a-helix). However, the circular dichroism spectrum of 
actobindin (Fig. 3) is consistent with the presence of only 
15% a-helix and 22% p-sheet structure. This would leave a 
major part of the molecule as either p-turn or coiled structure. 
DISCUSSION 
The symmetry in the actobindin sequence is likely to be 
reflected in the tertiary structure and function of the molecule. 
For instance, each of the repeated segments could constitute 
an actin-binding domain (possibly individually influenced by 
the nonrepetitive flanking sequences), which would explain 
the ability of actobindin to bind two molecules of monomeric 
actin (17). This hypothesis has been verified by identification 
of the side chains involved in chemical cross-linking between 
actin and actobindk4 Moreover, the demonstration (17) that 
actobindin associates with two actin monomers at high con- 
centrations of G-actin and one actin monomer at low concen- 
trations of G-actin is consistent with the observations (16) 
that actobindin inhibits the initial rate of actin polymeriza- 
tion much more effectively than it inhibits the rate of elon- 
gation of F-actin or the final concentration of F-actin. 
Comparison of the actobindin sequence with the sequences 
of other actin-binding proteins reveals some interesting rela- 
tionships (Fig. 4). The sequence of the first 6 residues in the 
two actobindin repeats is very similar to sequences in tropo- 
myosin, muscle myosin heavy chain, paramyosin, and Dic- 
tyostelium cY-actinin (Fig. 4A). Sequence similarities also occur 
among actobindin, mammalian profilins, and the two Acan- 
thamoeba profilin isoforms (Fig. 4B). Although Acanthamoeba 
actin, profilin, and actobindin all contain trimethyllysine 
residues, there is no similarity among the sequences surround- 
ing the trimethyllysines of these three amoeba proteins (Fig. 
4C). However, the sequences around the 2 trimethyllysines of 
actobindin are remarkably similar to the sequences flanking 
3 B. R. Beavis, B. T. Chait, M. R. Bubb, and E. D. Korn, unpub- 
lished results. 
4 K. Vancompernolle, J. Vandekerckhove, M. R. Bubb, and E. D. 
Korn, unpublished results. 
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FIG. 4. Amino acid sequence similarities between actobin- 
din and other proteins. A, comparison of actobindin with other 
actin-binding proteins: tropomyosin (22), muscle myosin heavy chain 
(23), paramyosin (24), and Dictyostelium cu-actinin (25); B, compari- 
son of actobindin with profilins (26-30); C, The amino acid sequences 
surrounding the trimethyllysine residues in Acanthmoeba actin (31), 
protilins (29,30), actobindin, and rabbit reticulocyte elongation factor 
la (32). Positions containing identical amino acids or conservative 
substitutions are boxed. 
the trimethyllysine in rabbit reticulocyte elongation factor la 
(Fig. 4C). 
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ELUTION TIME, MINUTES 
Fig. 1. Elation profiles of the reverse-phma HPLC separations of the CNBr-fragment and proteolytic peptides used to establish 
the sequmxm of actobindin. B_L intact actobindin, &L the CNBr-fragment, L the tryspin digest, L the endoproteinase Asp-N 
digest, Ty the Sta Dhvlococcus V8-protease digest, L the digest of the blocked NH2-terminal tryptic peptide (peptide 1-16 in panel 
c) with the VI-protease. The peptides whose sequences were used to establish the sequence of actobindin are identified by the 
positions of their first and last residues in the actobindin sequence (Fig. 2). The same conditions were used for all of the 
separations (see "Exoerimental Procedures"). 
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cycle CNBr-actobindin Asp-N(22) Asp-N(67) T(17)&T(53) T(24) T(39) T(4'3) T(76) T(l)-V8 V8(56) 
1 As” 556 Asp 852 Asp 498 His 703 ser a49 ser 548 ser 403 Gly 1719 Le” 203 Thr 576 
2 Pro 321 Lys 891 va1 471 Ala 654 Ala 1270 ser 409 Gly 765 Ala 1628 Gl" 190 Val 620 
Glu 376 ser 373 His 285 Gl" 344 Pro 802 Phe 615 Pro 691 Phe 1502 ser 81 Arp 498 
teu 340 Ala 637 va1 410 Thr 300 Gln 765 Le" 669 Ala 792 Ls" 1533 Ala 125 Lys 476 
Gl” 328 Pro 504 Lys 485 Val 204 Ile 623 Gl" 673 11e 549 Ser 763 11e 143 Ser 148 
Ser 178 Gl" 471 Asp 165 Glu 617 Gl" 601 Pro 522 Glu 1114 Gly 123 Gly 271 
Ala 287 11e 433 Val 346 Lys 136 As" 611 va1 354 Gl” 476 11e 911 Gl” 113 Pro 115 
Ile 242 Gl" 407 Asp 329 va1 351 Ala 448 Asp 453 Glu 713 Gly 111 Ala 175 
Gly 286 As" 388 Arg 152 Thr 428 Lys 436 va1 399 Lys 503 Ala 101 11e 101 



































Gly 295 Thr 196 Ai 271 Lys 143 His 211 va1 293 Le" 89 Glu 48 



















LyS 214 Le" 257 Le” 170 
Ser 162 Lys 101 
Val 271 Glu 146 
Asp 247 Ile 152 
Arg 212 Gl" 128 
ser 103 Lys 147 
se= 92 Ala 156 
Phe 115 Ala 123 
IA" 119 Lys 100 
















Amino acid sequences of CNBr-actobindin and the proteolytic fragments used to determine the actobindin sequence 
The peptides derived from cleavage with endoproteinase Asp-N, trypsin and Staphvlococcus VS-protease are identified ** Asp-N, T and 
V8, respectively. The number in parentheses identifies the position of the first residue of each peptide in the sequence of 
actobindin (Fig. 2). The purifications of the peptides are illustrated in Fig. 1. The yield in pm01 of the PTH-amino acid at each 
step in the Edman cycle follows the amino acid (40% of each sample w** applied to the seguenator). 
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